The Crop Microbiome Market Size is valued at USD 1.1 billion in 2023 and is predicted to reach USD 2.7 billion by the year 2031 at a 11.5% CAGR during the forecast period for 2024-2031.
The crop microbiome encompasses the diverse microorganisms associated with crops, including those in the soil (rhizosphere), on plant surfaces (phyllosphere), and within plant tissues (endosphere). These microbes are crucial for plant development, as they assist in nutrient cycling, protect against pathogens, and enhance plants' ability to withstand environmental stressors like drought and salinity. A wide range of agricultural production processes, including biocontrol, stress tolerance, soil fertility and quality, plant development promotion, and high-yield crop development, can be attributed to these bacteria.
The increased use of precision farming methods and advancements in biotechnology are driving the industry's phenomenal expansion. The need for microbiome-based solutions is also being driven by the growing adherence to organic agricultural methods and the enforcement of stringent regulations pertaining to the use of chemical pesticides. These elements come together to create an atmosphere that is favourable for the crop microbiome market's ongoing growth.
Furthermore, concerns about food security arising from both climate change and the world's expanding population are propelling the need for sustainable agricultural practices. Moreover, advancements in genetics, bioinformatics, and microbial research allow scientists to harness the beneficial traits of bacteria to enhance crops completely. In addition, legislative initiatives that support environmentally friendly farming practices and the decrease of chemical residues in food are driving market expansion.
Competitive Landscape
Some Major Key Players In The Crop Microbiome Market:
- BASF SE
- Certis USA LLC
- Marrone Bio Innovations Inc
- Sumitomo Chemical (Valent Biosciences LLC)
- Upl Ltd. (Arystalifescience Ltd.)
- Syngenta AG
- Hansen Holdings A/S
- Isagrospa
- Koppert BV
- Bioag Alliance (Bayer/Novozymes)
- Lallemand Inc.
- Verdesian Life Sciences LLC
- Italpollina AG
- Precision Laboratories LLC
- Other Market Players
Market Segmentation:
The crop microbiome market is segmented based on type and application. Based on type, the market is segmented into Bacteria, Fungi, Virus, and Other. By application, the market is segmented into Cereals, Oilseeds & Pulses, Fruits & Vegetables, and Other.
Based On The Type, The Bacteria Segment Accounts For A Major Contributor To The Crop Microbiome Market.
The bacteria category is expected to hold a major global market share in 2023. The growing number of bacteria used in the formulation of biostimulants, biopesticides, and fertilizers is primarily responsible for the segment's significant market share. The expansion of this market sector is influenced by bacteria, which are well-known for defending plants from numerous root-fungus infections and carrying out a number of other growth-enhancing tasks in plants. Furthermore, through enhancing soil structure, preventing soil-borne illnesses, and encouraging nutrient cycling, bacteria are essential to the upkeep of soil health. The segment's high share is a result of these causes.
Cereals Segment To Witness Growth At A Rapid Rate
The segment's substantial share is mostly attributable to the increased requirement to maximize cereal and grain output, reduce pest and disease-related cereal and grain loss, and use these commodities more frequently for animal feed, biofuel, and the manufacturing of starch and ethanol. Furthermore, because cereals and grains are essential for food security, governments in many nations actively promote their cultivation. Policies and subsidies that encourage the application of contemporary agricultural techniques, such as the use of crop microbiomes, are frequently included.
In The Region, The North American Crop Microbiome Market Holds A Significant Revenue Share.
The North American crop microbiome market is expected to report the highest market share in the near future. The initial factors driving the expansion of this market in the region are the growing awareness among farmers of the environmental benefits of microorganisms and the adoption of organic agriculture practices. The industry is expanding due to various causes, such as the increasing need for high-yield food produced by rapid urbanization. In addition, Asia Pacific is likely to grow rapidly in the global crop microbiome market because of the population's rapid growth, the rise in agricultural diseases, the adoption of environmental protection regulations, farmers' shift to organic farming, and the growing need for high yields and productivity.
Recent Developments:
- In April 2022, Ginkgo Bioworks and Bayer CropScience inked a deal whereby Ginkgo Bioworks will purchase Bayer's internal discovery and lead optimization platform, as well as its West Sacramento Biologics Research & Development location. This arrangement will probably hasten the global growers' access to Bayer's diverse portfolio of superior microbial-based solutions.
Crop Microbiome Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.1 Bn |
|
Revenue Forecast In 2031 |
USD 2.7 Bn |
|
Growth Rate CAGR |
CAGR of 11.5% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
BASF SE, Certis USA LLC, Marrone Bio Innovations Inc,Sumitomo Chemical (Valent Biosciences LLC),Upl Ltd. (Arystalifescience Ltd.),Syngenta AG, Chr. Hansen Holdings A/S, Isagrospa, Koppert BV,Bioag Alliance (Bayer/Novozymes),Lallemand Inc., Verdesian Life Sciences LLC, Italpollina AG, and Precision Laboratories LLC. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
